Clinical Trial Update: Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pembrolizumab in combination with chemoradiotherapy for muscle-invasive bladder cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-01-27